Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$10.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Nov 18, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 30,993 | $66.05 | $2M | -38.0% | Open the original filing on SEC.gov |
| Nov 18, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 24,007 | $65.23 | $1.6M | -22.7% | Open the original filing on SEC.gov |
| Nov 17, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 3,798 | $67.06 | $254.7K | -21.2% | Open the original filing on SEC.gov |
| Nov 17, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 36,801 | $66.63 | $2.5M | -67.3% | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT◆ | 8,425 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 6,589 | — | — | +13.7% | Open the original filing on SEC.gov |
| Jun 12, 2025 | ABCL | AbCellera Biologics Inc. | AGRANT◆ | 238,864 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 100,000 | $38.50 | $3.8M | -48.6% | Open the original filing on SEC.gov |